Metabolic effects of Lactobacillus reuteriDSM 17938 in people with type 2 diabetes: A randomized controlled trialDiabetes, Obesity and Metabolism - Tập 19 Số 4 - Trang 579-589 - 2017
Reza Mobini, Valentina Tremaroli, Marcus Ståhlman, Fredrik Karlsson, Max Levin, Maria Ljungberg, Maja Sohlin, Heléne Bertéus Forslund, Rosie Perkins, Fredrik Bäckhed, Per‐Anders Jansson
AimsTo investigate the metabolic effects of 12‐week oral supplementation with
Lactobacillus reuteri DSM 17938 in patients with type 2 diabetes on insulin therapy.M...... hiện toàn bộ
Treatment with LY2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetesDiabetes, Obesity and Metabolism - Tập 19 Số 11 - Trang 1521-1528 - 2017
Cristina B. Guzmán, Xiaotian Michelle Zhang, Rong Liu, Arie Regev, Sudha S. Shankar, Parag Garhyan, Sreekumar Pillai, C Kazda, Naga Chalasani, Thomas A. Hardy
AimsTo evaluate whether treatment with LY2409021, a novel, selective glucagon receptor antagonist, is associated with changes in hepatic fat and other safety variables related to the benefit–risk profile for chronic use in patients with type 2 diabetes (T...... hiện toàn bộ
Tofogliflozin decreases body fat mass and improves peripheral insulin resistanceDiabetes, Obesity and Metabolism - Tập 20 Số 5 - Trang 1311-1315 - 2018
Ren Matsuba, Ikuro Matsuba, Mototsugu Shimokawa, Yoshio Nagai, Yasushi Tanaka
The impact of tofogliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on peripheral glucose uptake in patients with type 2 diabetes mellitus (T2DM) was investigated using the hyperinsulinaemic‐euglycaemic clamp method in a single‐arm, open‐label study. The following variables were compared between before and after tofogliflozin administration for 12 weeks in 16 patients with T2DM who w...... hiện toàn bộ
Long‐term efficacy and safety of canagliflozin over 104 weeks in patients aged 55–80 years with type 2 diabetesDiabetes, Obesity and Metabolism - Tập 17 Số 3 - Trang 294-303 - 2015
Bruce W. Bode, Kaj Stenlöf, Stewart B. Harris, Daniel J. Sullivan, Albert Fung, Keith Usiskin, Gary Meininger
AimsThe long‐term efficacy and safety of canagliflozin, a sodium glucose co‐transporter 2 inhibitor, was evaluated over 104 weeks in patients aged 55–80 years with type 2 diabetes mellitus (T2DM) inadequately controlled on a stable antihyperglycaemic agent regimen....... hiện toàn bộ
Body fat distribution is more predictive of all‐cause mortality than overall adiposityDiabetes, Obesity and Metabolism - Tập 20 Số 1 - Trang 141-147 - 2018
Sung Woo Lee, Jee Young Son, Jeong‐Min Kim, Seung-Sik Hwang, Jin Suk Han, Nam Ju Heo
AimsThe relationship between directly measured body fat and all‐cause mortality has been rarely studied. The aim of this study was to evaluate the predictive significance of computed tomography (CT)‐measured body fat, including both visceral fat area (VFA...... hiện toàn bộ